CCR7 and neoplasm: In these scenarios, tumor cells often exhibit CCR7 positivity alongside increased extracellular matrix levels of CCL21, supporting enhanced migratory capacity mediated via the PI3K/Akt and mTOR signaling pathways (33, 38, 39).